Longitudinal, Multicenter Study of Clinical Factors Impacting Health-Related Quality of Life in Paediatric Autoimmune Liver Disease.
Rebecca Farr, Cyd Castro Rojas, Mosab Alquraish...
https://pubmed.ncbi.nlm.nih.gov/41804276/Actively Recruiting
Led by Children's Hospital Medical Center, Cincinnati · Updated on 2026-08-19
800
Participants Needed
8
Research Sites
25 weeks
Total Duration
Researchers are establishing the Autoimmune Liver disease Network for Kids A-LiNK, a multi-institutional effort to improve care for children, adolescents, and young adults with pediatric autoimmune liver diseases such as autoimmune hepatitis AIH and primary sclerosing cholangitis PSC. These conditions present diagnostic and therapeutic challenges, with no accepted guidelines for monitoring or symptom management, leading to varied treatments and liver transplants in severe cases. The study aims to create a shared clinical registry and a learning health network to enhance patient-centered outcomes research and improve quality of life. This observational study collects clinical measurement data and information about care processes from participating sites without providing any interventions. The network promotes transparent data sharing across centers, focusing on patient and family-centered approaches rather than traditional investigator-driven research. The registry will compile disease characteristics, relapse rates, complications, side effects of steroid treatments, and disparities related to race and ethnicity. Participants will contribute clinical data over time, which will be analyzed to assess baseline disease features, remission and relapse rates, and quality of life using tools like the Pediatric Quality of Life Inventory PedsQL 4.0. The study also monitors complications and steroid side effects. The research is ongoing with outcomes expected by 2034, aiming to enhance understanding and care of pediatric autoimmune liver disease through collaborative data sharing and learning.
CONDITIONS
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
A
Amy E Taylor, MD
C
Cyd M Castro-Rojas, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Rebecca Farr, Cyd Castro Rojas, Mosab Alquraish...
https://pubmed.ncbi.nlm.nih.gov/41804276/Children's Hospital Medical Center, Cincinnati
Lead Sponsor